Swanson Reed News

Startups Using Accrued R&D Tax Offsets to Access Finance Ahead of Lodgement

May 5th, 2020

An Article in the Sydney Morning Herald during the week has highlighted the increasing trend of companies seeking finance based on anticipated R&D Tax Entitlements. This allows companies to access funding now, based on a portion of what their anticipated R&D Refund is expected to be, once claims can be lodged after 30 June. Providers of such finance usually require: interim financial statements and R&D Calculations to be reviewed in detail; an assessment of the companies R&D Activities to be undertaken […]

Read More

STA Lobbying for Australia to Have Greater “Sovereign Capability” in Manufacturing, Underpinned by Strong R&D

April 27th, 2020

In the wake of the COVID-19 situation, there has been numerous parties lobbying that: Not only should the R&D Tax reforms proposed to apply for FY20 be abandoned; but The government should also implement measures to enhance incentives for business investment in R&D. InnovationAus has reported that Science & Technology Australia (STA) has proposed: If the government’s proposed reduction to the R&D Tax Incentive were implemented, that any savings be directed to a research translation fund to help Australia build greater […]

Read More

AusIndustry Lodgement Concessions on Finding Applications due on 30 June 2020

April 20th, 2020

Companies seeking to claim overseas expenditure, or seeking an advance determination on eligibility of a project must lodge a finding Application period to the end of the financial year in which the activity is first conducted (i.e. 30 June for activities in FY20). During a finding process, AusIndustry provides a binding determination of eligibility, and an enormous amount of work must be put into such applications, including the collation of a vast amount of supporting evidence. There is no provision […]

Read More

R&D Tax Incentive Advocate CSL Rapidly Adapts R&D Effort to focus on COVID-19

April 14th, 2020

The Australian newspaper has digested the ASX announcement of CSL late last week and detailed how the company, which recently has overtaken CBA as the largest cap stock on the ASX, has rapidly adapted its R&D Effort in response to the COVID-19 situation. The article reports: The health challenges presented by COVID-19 have led to delays in the ability to conduct clinical trials and to progress candidates within the company’s existing pipeline; CSL remains on track to invest 10% of […]

Read More

Bryce Steele
Principal, Melbourne
Tel: (03) 9018 5778
Mob: 0435 713 493
Tom Parkhouse
Principal, Sydney
Tel: (02) 8006 0559
Mob: 0435 713 493
Andy Nguyen
Principal, Brisbane
Tel: (07) 3221 1499
Mob: 0407 750 249
Kieu McKellar
Manager, Adelaide
Tel: (08) 8121 7850
Mob: 0435 713 493
David Greatwich
Principal, Perth
Tel: (08) 9340 3745
Mob: 0468 386 250
Krishna Gungaram
Manager, Hobart
Tel: (03) 9018 5778
Mob: 0435 713 493



    Email this job